March 8-9, 2022
Day 1
Session 1: Neuroimmunology
Convenor: Cynthia Ju, Univ. of Texas Health Science Center
Co-convenor: Dorothea R. Morris, Univ. of Texas Medical Branch
2:00-2:45 Keynote
A Lymphopoietic Niche at the CNS Borders
Marco Colonna, MD, Washington University
Session 1
2:45-3:05 SARS-CoV2-mediated Neuroimmune Responses Trigger Alzheimer’s Disease Neuropathology
Irma Cisneros, Univ. of Texas Medical Branch
3:05-3:20 Immunotherapy in Glioblastoma; Gleaning from the Past, Approaching the Present and Projecting into the Future
Lordstrong Akano, Univ. of Ibadan
3:20-3:40 Break
3:40-3:55 Developing a Chronic Model of Candida albicans Cerebral Mycosis Through Gut Colonization
Lynn Bimler, Baylor College of Medicine
3:55 4:10 Concerted Cellular Responses to Type I Interferon Propel Memory Impairment Associated with Amyloid β Plaques
Ethan Roy, Baylor College of Medicine
4:10-5:40 pm Poster session (event hall)
Day 2
8:30 Welcome
Suzanne Tomlinson and David Corry
Session 2: Immunology of Pathogen Infections
Convenor: David Corry, Baylor College of Medicine
Co-convenor: Lynn Bimler, Baylor College of Medicine
8:40 Keynote
Activation of Host Immune Responses by candidalysin
Julian Naglik, King’s College, London
9:25 Gut Microbiota from Sjögren Syndrome Patients Causes Decreased T regulatory Cells in the Lymphoid Organs and Desiccation-induced Corneal Barrier Disruption in Mice
Cintia de Paiva, Baylor College of Medicine
9:45 Antimicrobial Peptide Deficiency in Allergic Fungal Rhinosinusitis
Amber Luong, Univ. of Texas Health Science Center Houston
10:05 Defects in Macrophage Galactose-type Lectin (MGL) Signaling and Pathogenesis of Mycobacterium tuberculosis and Human Immunodeficiency Virus co-infection
Sarah Browning, Univ. of Texas Medical Branch
10:20 Break
Session 3: Bioengineering in Immunology
Convenor: Momoko Yoshimoto, Univ. of Texas Health Science Center
Co-convenor: Bashir Uddin, Univ. of Texas Medical Branch
10:35 Keynote
One Ellipsoid to Control them all — Peptoid Anti-infectives that are Antiviral, Antibacterial & Antifungal and Well-tolerated in the Lung
Annelise Barron, Stanford Univ.
11:20 BRCA/FANC Tumor Suppressors Prevent Mitochondrial Immune Signaling and T-ALL in Mice
Katharina Schlacher, MD Anderson Cancer Center
11:40 A Population of M2 Macrophages Associated with Bone Formation
Alan Davis, Baylor College of Medicine
12:00 Cathepsin S Inhibitor Diet Improves Inflammation in the Lacrimal Gland in CD25KO Mice
Kaitlin Scholand, Rice Univ.
12:15 G-Quadruplexes in Aging of the Immune System
Andrey Tsvetkov, Univ. of Texas Health Science Center
12:30-2:00 Lunch
Session 4: Cancer and Immunology
Convenor: Maksim Mamonkin, Baylor College of Medicine
Co-convenor: Bhakti Patel, MD Anderson Cancer Center
2:00-2:45 Keynote
T Cell Therapy of Cancer: Faster, Higher, Stronger….
Cassian Yee, MD Anderson Cancer Center
2:45 Urinary T Cells are Detected in Patients with ICI-associated Immune Nephritis
Jamie Lin, MD Anderson Cancer Center
3:05 Dendritic Cell Governance of an Innate-like Cytotoxic Effector Memory CD8+CD161+ T Cell Subset
Vanaja Konduri, Baylor College of Medicine
3:25 Break
3:40-4:00 Pyroptosis: A New Avenue for Cancer Cell Elimination
Zhibin Zhang, MD Anderson Cancer Center
4:00 Bone Marrow Stromal Antigen 2 Facilitates Activation of Hematopoietic Stem Cell Through the Induction of ERK Signaling
Marcus Florez, Baylor College of Medicine
4:15 Pharmacologic Degradation of RIPK1 Enhances Anti-Tumor Immunity
Xin Yu, Baylor College of Medicine
4:30 Late CTLA-4 Ig Treatment Improves Antitumor Efficacy of Immunotherapy
Stephen Mok, MD Anderson Cancer Center
4:45 Technology talk
Cellular Cartography by Mass Cytometry
Jared K. Burks, MD Anderson Cancer Center
5:15 Closing remarks